Active Pharmaceutical Ingredients (API) Market - Global Outlook & Forecast 2021-2026

Active Pharmaceutical Ingredients (API) Market - Global Outlook & Forecast 2021-2026

  • November 2021 •
  • 284 pages •
  • Report ID: 6179129 •
  • Format: PDF
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Active Pharmaceutical Ingredients Market Report

The active pharmaceutical ingredients market is expected to reach USD 266.80 billion by 2026, growing at a CAGR of 6.22%.

The following factors are likely to contribute to the growth of the active pharmaceutical ingredients market during the forecast period:

• The invention of new generation API
• Increase in Demand for Generic Drugs
• High Adoption of Mergers and Acquisitions
• Impact of API Outsourcing

ACTIVE PHARMACEUTICAL INGREDIENT MARKET OUTLOOK

Digitalization, big data, and artificial intelligence are accelerating the transformation of the pharmaceutical industry. The growing trend toward new high-tech therapeutics, with the emergence of novel and innovative delivery systems, the evolution of personalized medicines, will emphasize the growing demand for advanced APIs further. Innovative and Biotech APIs are fueling the demand for APIs across the globe. The global active pharmaceutical ingredient (API) market is set to have significant growth in the forecasted period. The growth of the market can be amplified by the growing geriatric and aging population globally. Manufacturers are significantly investing in Research and development and must continue spending on research and development initiatives. As the industry is getting fragmented and profit margins are thin, there is a need for constant innovation.

SNIPPETS

• Based on Molecule type, the small molecule is the largest segment with a 5.82% growth rate in 2021 and is projected to show a 6.95% growth rate in 2026.
• Current trends like an increase in demand for biopharmaceuticals and naturally derived APIs will increase the demand and growth in the market.

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION
This research report includes a detailed segmentation by

• Application
• Molecule Type
• Type of manufacturers
• Type of drugs
• Synthesis Type

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTS

• The increasing awareness of various APIs’ improved efficacy on targeted cancerous cells is also propelling their demand for oncology drugs. Oncology API will register a growth rate of 7.33% in 2021, and it will increase up to 8.18% in 2026.
• The rise in internet penetration enables various online platforms to collaborate with pharmaceutical companies to deliver drugs such as analgesics at the doorstep of consumers. The global active pharmaceutical ingredients industry by pain management API will grow at a CAGR of 5.76% during the forecast period.

Market Segmentation by Application
• Oncology
• Cardiovascular Disease
• Anti-infectives
• Central Nervous System
• Respiratory diseases
• Diabetes
• Pain management
• Others

Market Segmentation by Molecule Type
• Small
• Large

Market Segmentation by Type of manufacturers
• Captive
• Merchant

Market Segmentation by Type of drugs
• Prescription
• Over the counter

Market Segmentation by Synthesis Type
• Synthetic
• Biotech

GEOGRAPHICAL ANALYSIS
The North American region is highly fragmented, and many global and regional players are present in the active pharmaceutical ingredient industry. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. The North American API industry is anticipated to show increasing growth in the forecasted period.

Market Segmentation by Geography

• North America
o US
o Canada
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Russia
• APAC
o China
o India
o Indonesia
o Japan
o Singapore
• Latin America
o Brazil
o Mexico
• Middle East & Africa
o Saudi Arabia
o South Africa
o UAE

VENDORS ANALYSIS

The global API market is highly concentrated and competitive. Pfizer, Cipla, Novartis AG, Mylan NV, and Sun Pharmaceuticals are prominent vendors in the industry. Over the past decade, several companies have engaged in mergers and acquisitions to establish their presence in the industry. Mergers and acquisitions offer several benefits, such as better access to procuring raw materials, distribution, and R&D, and are largely driven by consolidation. Manufacturers must always keep pace with the latest industry regulations for manufacturing APIs to avoid penalties and criminal sanctions. The demand for APIs is expected to accelerate due to the increase in the geriatric population and the increase in awareness for better healthcare.

Key Vendors

• Pfizer Inc.
• Cipla Inc.
• Novartis AG
• Mylan N.V.
• Sun Pharmaceuticals Industries Ltd.

Other Prominent Vendors

• Albemarle Corporation
• AbbVie Inc.
• Reddy’s Laboratories Ltd.
• Eli Lilly and Company
• Teva Pharmaceuticals Industries Ltd.
• Bristol-Myers Squibb
• Aurobindo Pharma limited
• Sanofi
• Boehringer Ingelheim International GmbH
• BASF SE
• Lupin
• Shenzhen Hepalink Pharmaceutical Group Ltd.
• Abbott
• Biocon
• Amgen Inc.
• GlaxoSmithKline Plc
• Hoffmann-La Roche Ltd.
• Merck KGaA
• Viatris Inc.,
• Glenmark Pharmaceuticals

KEY QUESTIONS ANSWERED:

1. How big is the active pharmaceutical ingredient market?
2. What are the different applications in the global active pharmaceutical ingredient market?
3. Who are the key players in the active pharmaceutical ingredient (API) market?
4. What are the latest trends in the active pharmaceutical ingredient market?
5. What are the key driving factors in the global API market?
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.